Effect of Lycopene Supplementation on Some Cardiovascular Risk Factors and Markers of Endothelial Function in Iranian Patients with Ischemic Heart Failure: A Randomized Clinical Trial

Table 1

Summary of the results.

Variables		Case (N = 22) (mean ± Sd)	Control (N = 21) (mean ± Sd)	value^I
TG	Before	247.36 ± 16.80	247.67 ± 17.77	0.874
	After 2 months	219.27 ± 19.48	234.24 ± 17.48	0.002
	value^II	<0.001	<0.001
TC	Before	205.32 ± 29.31	201.43 ± 14.46	0.836
	After 2 months	181.09 ± 31.21	175.95 ± 24.38	0.301
	value^II	<0.001	<0.001
HDL-C	Before	42.86 ± 7.16	43.43 ± 6.80	0.788
	After 2 months	45.64 ± 8.35	46.43 ± 8.03	0.733
	value^II	0.002	0.001
LDL-C	Before	76.50 ± 15.17	73.86 ± 14.98	0.519
	After 2 months	61.77 ± 15.64	66.76 ± 14.94	0.325
	value^II	<0.001	<0.001
SBP	Before	120.64 ± 16.19	121.38 ± 16.05	0.893
	After 2 months	116.64 ± 17.12	118.48 ± 14.46	0.635
	value^II	0.002	0.225
DBP	Before	77.18 ± 8.51	78.10 ± 9.28	0.806
	After 2 months	77.05 ± 8.23	77.52 ± 9.23	0.815
	value^II	0.702	0.725
FMD	Before	2.36 ± 1.26	2.62 ± 1.83	0.784
	After 2 months	5.68 ± 1.81	2.95 ± 1.50	<0.001
	value^II	<0.001	0.115

I: Mann–Whitney test; II: Kruskal–Wallis test.